Fort Dodge Animal Health | Zoetis | economic sanction violation | 2004 | OFAC | $26,956 |
Alpharma Animal Health Division | Zoetis | environmental violation | 2002 | AR-ENV | $9,394 |
Alpharma Animal Health Division | Zoetis | environmental violation | 2001 | AR-ENV | $80,000 |
ZOETIS LLC | Zoetis | environmental violation | 2019 | MI-ENV | $14,625 |
ALPHARMA ANIMAL HEALTH COMPANY | Zoetis | workplace safety or health violation | 2001 | OSHA | $18,300 |
ALPHARMA ANIMAL HEALTH COMPANY | Zoetis | workplace safety or health violation | 2001 | OSHA | $25,600 |
ZOETIS, LLC | Zoetis | workplace safety or health violation | 2015 | OSHA | $7,140 |
ZOETIS, LLC | Zoetis | workplace safety or health violation | 2015 | OSHA | $14,700 |
ALPHARMA, INC. | Zoetis | environmental violation | 2000 | EPA | $5,000 |
Alpharma Inc. (Chicago Heights) | Zoetis | environmental violation | 2006 | EPA | $29,737 |
Wockhardt USA | Wockhardt Limited | Medicare Coverage Gap Discount Program violation | 2020 | CMS | $111,824 |
Morton Grove Pharmaceuticals, Inc. | Wockhardt Limited | campaign finance violation | 2007 | FEC | $9,000 |
Wockhardt Limited | Wockhardt Limited | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $340,000 |
WOCKHARDT USA MORTON GROVE DBA MORTON GROVE PHARMACEUTICALS, INC. | Wockhardt Limited | workplace safety or health violation | 2019 | OSHA | $7,900 |
Dey Inc. | Viatris | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Mylan Laboratories, Inc. | Viatris | consumer protection violation | 2000 | FTC | $100,000,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | DOJ_CIVIL | $18,500,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
Mylan | Viatris | wage and hour violation | 2014 | private lawsuit-federal | $225,000 |
Dey | Viatris | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2004 | WV-AG | $850,000 |
Dey L.P. | Viatris | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Dey Labs | Viatris | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey LP | Viatris | False Claims Act and related | 2007 | MT-AG | $198,000 |
Dey Pharmaceuticals | Viatris | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
Dey, Inc. | Viatris | fraud | 2004 | AR-AG | $600,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | NV-AG | $670,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Laboratories et al. | Viatris | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | False Claims Act and related | 2012 | ID-AG | $625,000 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
Mylan Specialty L.P. | Viatris | consumer protection violation | 2013 | OR-AG | $250,000 |
Mylan Specialty, L.P. | Viatris | off-label or unapproved promotion of medical products | 2013 | MA-AG | $250,000 |
Mylan N.V. | Viatris | investor protection violation | 2019 | SEC | $30,000,000 |
Dey, Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $96,525,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $14,377,600 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
Mylan N.V. | Viatris | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $264,000,000 |
MYLAN TECHNOLOGIES, INC. | Viatris | workplace safety or health violation | 2021 | OSHA | $13,653 |
United Therapeutics Corporation | United Therapeutics | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | DOJ_CIVIL | $22,000,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,756,164 |
UCB | UCB | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
UCB Holdings, Inc. | UCB | benefit plan administrator violation | 2017 | private lawsuit-federal | $5,500,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322 |
UCB Pharma, Inc. | UCB | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
UCB Chemicals Corporation | UCB | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
SCHWARZ PHARMA MANUFACTURING, INC. | UCB | workplace safety or health violation | 2010 | OSHA | $6,750 |
UCB CHEMICAL CORPORATION | UCB | environmental violation | 2001 | EPA | $6,824 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | environmental violation | 2013 | EPA | $2,250,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | DOJ_CIVIL | $14,000,000 |
Cephalon Inc | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | FDA | $425,000,000 |
Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
Valmed Pharmaceutical, Inc. | Teva Pharmaceutical Industries | wage and hour violation | 2004 | WHD | $83,871 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $600,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Anda | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Andrx Corporation | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Cephalon | Teva Pharmaceutical Industries | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | consumer protection violation | 2019 | CA-AG | $69,000,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2019 | OK-AG | $85,000,000 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | environmental violation | 2003 | MO-AG | $70,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |